Roger Jeffs Sells 25,000 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 25,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $40.10, for a total transaction of $1,002,500.00. Following the completion of the transaction, the chief executive officer owned 1,398,095 shares in the company, valued at $56,063,609.50. The trade was a 1.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $42.09, for a total transaction of $1,052,250.00.
• On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The shares were sold at an average price of $40.60, for a total transaction of $764,863.40.
• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total transaction of $1,003,500.00.
• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total transaction of $132,000.00.
• On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The shares were sold at an average price of $38.37, for a total transaction of $1,256,387.28.
• On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total transaction of $859,891.96.
• On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total transaction of $1,003,000.00.

Liquidia Price Performance

Shares of NASDAQ LQDA opened at $42.40 on Friday. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $46.67. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.01 and a quick ratio of 1.84. The company’s 50-day moving average is $36.96 and its 200 day moving average is $34.71. The stock has a market capitalization of $3.77 billion, a P/E ratio of -51.08 and a beta of 0.41.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings results on Thursday, March 5th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.07. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The company had revenue of $92.02 million for the quarter, compared to analysts’ expectations of $87.49 million. The business’s quarterly revenue was up 3072.4% compared to the same quarter last year. On average, sell-side analysts expect that Liquidia Corporation will post 1.75 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on LQDA shares. Wall Street Zen upgraded shares of Liquidia from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Raymond James Financial reiterated a “strong-buy” rating on shares of Liquidia in a research report on Thursday, March 5th. Oppenheimer boosted their price target on shares of Liquidia from $16.00 to $19.00 and gave the company an “underperform” rating in a research report on Thursday, March 12th. HC Wainwright boosted their price target on shares of Liquidia from $50.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Finally, BTIG Research boosted their price target on shares of Liquidia from $49.00 to $50.00 and gave the company a “buy” rating in a research report on Thursday, March 5th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Liquidia presently has a consensus rating of “Moderate Buy” and an average target price of $43.44.

Institutional Investors Weigh In On Liquidia

Hedge funds and other institutional investors have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. purchased a new stake in Liquidia in the fourth quarter worth about $25,000. Covestor Ltd grew its holdings in Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after purchasing an additional 359 shares during the period. Skandinaviska Enskilda Banken AB publ purchased a new stake in Liquidia in the third quarter worth about $30,000. FNY Investment Advisers LLC purchased a new stake in Liquidia in the third quarter worth about $34,000. Finally, NewEdge Advisors LLC purchased a new stake in Liquidia in the second quarter worth about $25,000. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).